Felbamate Tablet
Product Images NDC 51672-4185
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Felbamate (NDC 51672-4185). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Taro Pharmaceuticals U.s.a., Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (400 mg Tablet Bottle Label)
NDC 51672-4185-1 is a medication that contains Felbamate as the active ingredient. It is available in the form of tablets, and each tablet contains 400 mg of Felbamate. It is advised to read the accompanying medication guide before using the medication. Store in a controlled room temperature between 20°C to 25°C. The medicine is distributed by Taro Pharmaceuticals USA, Inc. and is a registered trademark of Taro Pharmaceutical US. Full prescribing information is available in the package insert.*
Principal Display Panel (600 mg Tablet Bottle Label)
This is a description of a medication called Felbamate. Each tablet contains 600mg of the medication and should be dispensed in a tight container. The usual dosage information can be found in the package insert. The medication guide should be provided with the tablets. It is manufactured by Taro Pharmaceutical Industries Ltd and distributed by Taro Pharmaceuticals U.S.A., Inc. It has a National Drug Code (NDC) of 51672-4186-1 and comes in a package of 100 tablets. The medication should be stored at a temperature between 20°C to 25°C (68°F to 77°F).*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.